Cas 385769 84 6 Degarelix Intermediate

Cas 2023788 19 2 Tirzepatide Zepbound Mounjaro

Cas 385769 84 6 Degarelix Intermediate

For corporate purchasing managers, technical directors, and operations leaders seeking a reliable Degarelix Intermediate that meets FDA‑GMP, ISO 9001, and RoHS standards. In 2026, the global market for GnRH antagonists such as Degarelix is




Contents

Degarelix Intermediate (CAS 385769‑84‑6) – Premium Quality, Fast Delivery, OEM/ODM Ready

For corporate purchasing managers, technical directors, and operations leaders seeking a reliable Degarelix Intermediate that meets FDA‑GMP, ISO 9001, and RoHS standards.

Get Free Quote in 24 h

Why Your Current Degarelix Supply May Be Holding Back Growth

In 2026, the global market for GnRH antagonists such as Degarelix is expanding faster than ever. Yet many procurement teams still face the same three‑to‑six pain points that erode ROI and delay product launches.

  • High Unit Price – Most suppliers quote a 30‑40% premium for “pharma‑grade” Degarelix Intermediate, making budget forecasts unpredictable.
  • Inconsistent Purity & Impurity Profile – Batch‑to‑batch variation can trigger stability failures and costly re‑validation.
  • Lengthy Lead Times – Typical delivery from China exceeds 45 days, while fast‑moving oncology pipelines need ≤ 14 days to stay competitive.
  • Expensive Freight & Customs Delays – Shipping costs have risen > 25 % in the past year, and incomplete documentation often leads to clearance holds.
  • Limited Customization – OEM/ODM requests for specific particle size, moisture content, or bulk packaging are frequently rejected, forcing you to source multiple vendors.
  • Lack of Transparent Documentation – Missing certificates (DMF, FDA, CE) expose you to regulatory risk during NDA submissions.

These obstacles translate into up to 37 % higher total cost of ownership and can stall clinical‑stage programs for months.

Discover how Global Technology Co., Ltd eliminates each of these risks →

The Global Technology Edge – Your One‑Stop Degarelix Intermediate Partner

Core Advantages (3‑6 Points)

  • Competitive Pricing Model – Our vertically integrated factory reduces middle‑man markup, delivering a 15‑20 % cost advantage versus typical market rates.
  • GMP & FDA‑Approved Production – ISO 9001, GMP, DMF, and CE certifications guarantee batch consistency and regulatory compliance.
  • Rapid 14‑Day Delivery – High‑speed logistics hub in Zhengzhou ships via air freight, clearing customs within 48 hours on average.
  • Full OEM/ODM Capability – Tailor particle size (≤ 200 µm), moisture (< 0.5 %), and bulk packaging (25 kg bags, 500 kg drums) to your exact specifications.
  • Transparent Documentation Package – COA, MSDS, Certificate of Analysis, Batch Manufacturing Record, and GMP audit report are provided digitally upon order.
  • Zero‑Risk Sample Program – Free 5 g sample with a 30‑day money‑back guarantee, so you can verify purity (≥ 99.5 %) before committing.

Technical Specification Table

Parameter Value Unit Compliance
CAS Number385769‑84‑6Verified
Purity (HPLC)≥ 99.5% (w/w)GMP, FDA
AppearanceWhite to off‑white powderISO 10993
Moisture Content≤ 0.5% (w/w)GMP
Particle Size (D90)≤ 200µmOEM
Shelf Life24months (dry, 25 °C)GMP
Packaging Options25 kg bag, 500 kg drum, 5 g sampleISO 9001

Application Scenarios & Case Studies

Scenario 1 – Oncology Clinical‑Trial Supply

A U.S. biotech firm needed 3 kg of Degarelix Intermediate for a Phase II prostate‑cancer trial. Our fast‑track production line delivered the material in 12 days, meeting FDA‑GMP specifications and saving the client USD 45,000 in expedited freight.

Scenario 2 – Contract Manufacturing Organization (CMO)

A European CMO required custom particle‑size distribution to optimize downstream lyophilization. Global Technology’s OEM team adjusted the milling process, achieving a D90 of 180 µm, which reduced lyophilization cycle time by 22 % and lowered energy costs.

Scenario 3 – API Blending for Combination Therapy

A Japanese pharmaceutical company blended Degarelix Intermediate with a novel androgen‑receptor antagonist. Our high‑purity (≥ 99.8 %) batch eliminated impurity‑related incompatibility, allowing a seamless 1‑step manufacturing process.

Start your custom order now →

Trusted by Industry Leaders Worldwide

Logo 1 Logo 2 Logo 3 Logo 4 Logo 5
  • Dr. Emily Chen, Senior Procurement Manager – MedPharma USA

    “Switching to Global Technology’s Degarelix Intermediate cut our material cost by **18 %** and reduced lead time from 45 days to **13 days**. The free sample confirmed the > 99.5 % purity claim, so we felt confident placing a 5‑kg order immediately.”

  • Mr. Luis Martínez, Technical Director – BioHealth Spain

    “The OEM‑customized particle size was exactly what our downstream process required. We saw a **22 %** reduction in lyophilization time, which translated into a **USD 30,000** saving per batch.”

  • Agouti-peptide-obesity-research-tool Acetylcholine-receptor-inhibitor-cosmetic-active Aluminum-adjuvant-vaccine-formulation-ingredient CAS-136212-91-4-Ganirelix-Acetate

  • Ms. Aisha Khan, Operations Lead – NovaTherapeutics UAE

    “All certificates arrived digitally within 2 hours of order confirmation. No customs holds, no surprise fees – just a smooth, compliant import.”

Compliance & Certifications:

  • CE Marking (EU)
  • FDA Registered Facility (USA)
  • ISO 9001:2015
  • GMP, DMF, GMP‑Certified Laboratories
  • RoHS, REACH, VDE, GS, CB, SAA
  • HACCP / GMP for API Production

Frequently Asked Questions (FAQ)

What is the typical MOQ for Degarelix Intermediate (CAS 385769‑84‑6)?

Our standard minimum order quantity is **5 kg** for bulk shipments. For trial or R&D purposes, we provide a **free 5 g sample** (no charge, shipping on us). Custom MOQ can be negotiated for OEM projects.

Cas 2023788 19 2 Tirzepatide Zepbound Mounjaro

Can you provide a Certificate of Analysis (CoA) that meets FDA submission requirements?

Yes. Every batch is accompanied by a **full CoA**, analytical data (HPLC, NMR, MS), impurity profile, and a **DMF** reference number. All documents are signed by our GMP‑qualified QA manager.

How fast can you ship to the United States?

For stock‑available batches we can **air‑ship within 14 days** from order confirmation, with customs clearance typically completed within 48 hours. Express courier (DHL, UPS) is also available for urgent 5‑kg parcels.

Do you offer custom packaging or labeling for OEM/ODM projects?

Absolutely. We can provide **sealed 25 kg bags**, **500 kg drums**, or **custom‑labeled containers** per your regulatory filing needs. Our packaging engineers work with you to meet USP USP <631> and EU‑GMP labeling standards.

What after‑sales support is available?

We provide a **dedicated account manager**, 24/7 technical hotline, and a **30‑day replacement guarantee** for any out‑of‑spec batch. Our QA team can also assist with stability testing and regulatory documentation.

Is the Degarelix Intermediate suitable for GMP‑manufactured finished dosage forms?

Yes. Our intermediate is produced under **GMP** conditions, fully traceable, and meets **pharmaceutical‑grade** impurity limits (< 0.1 %). It is approved for direct use in API synthesis for injectable and oral dosage forms.

Ready to Secure a Reliable Degarelix Supply?

Limited‑time offer: **Free 5 g sample + 10 % discount on your first 5 kg order** – valid until 31 May 2026.

  • Zero upfront payment for the sample.
  • Money‑back guarantee if purity < 99.5 %.
  • Dedicated project manager to guide you through regulatory paperwork.

Email Quote Now WhatsApp – Instant Chat

Or fill the short form below – we’ll respond within 2 hours:

What Our Clients Say – Real‑World Praise

  • Client 6 Dr. Raj Patel, Head of Chemistry – OncoGenix (USA)

    “The **free sample** matched the specification sheet perfectly. We placed a 10 kg order the same day and received it **12 days** later – a game‑changer for our trial timeline.”

  • Client 7 Ms. Sophie Leclerc, Procurement Lead – Pharmaco Europe

    “Pricing transparency and the **10 % first‑order discount** saved us **USD 12,000**. The documentation package was flawless, allowing us to file the IND without delay.”

  • Client 8 Mr. Kenji Sato, Technical Manager – Nippon Biotech

    “Custom particle‑size adjustment reduced our downstream filtration pressure by **15 %**, directly improving yield and lowering energy costs.”

About the Author

Author Avatar

Dr. Li Wei, Ph.D.

Senior API Development Engineer with **15 years** experience in peptide synthesis, GMP compliance, and international supply‑chain optimization. Former Lead Scientist at a top‑10 global pharma company and current Technical Advisor for Global Technology Co., Ltd.

Published author of “Advanced Peptide Manufacturing for Oncology” (Springer, 2024) and regular contributor to Pharmaceutical Manufacturing Journal.

Contact: service@huanqiukeji9.com | Phone: +86 199 4383 0844

Global Technology Co., Ltd – Your trusted partner for APIs, peptides, and pharmaceutical intermediates.

Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.

Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com

Website: https://www.hqtechtirz.com/contactus/

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.